A porcine model of Fanconi anemia

PLoS One. 2025 Oct 31;20(10):e0335854. doi: 10.1371/journal.pone.0335854. eCollection 2025.

Abstract

Although small animal models of Fanconi anemia (FA) are useful, they do not faithfully replicate many of the clinical features seen in FA patients. We reasoned that a porcine model of FA with its similar physiology and a relatively long lifespan would produce a phenotype more similar to human FA. Targeting FANCA in domestic swine resulted in skeletal abnormalities and extreme sensitivity to interstrand DNA cross-linking agents. In addition, FANCA disruption followed by mitomycin C treatment resulted in a > 10-fold increase in chromosomal radials, a finding that is considered diagnostic for human FA. Bone marrow derived, hematopoietic progenitor cells from a FANCA null pig showed a 75% reduction in colony forming activity compared to wild type. Evaluation of steady state hematopoiesis in the peripheral blood revealed the gradual development of red cell macrocytosis and a reduction in circulating neutrophils. Targeting of FANCD2 failed to produce any biallelic animals demonstrating the loss of FANCD2 function is embryonic lethal in pigs. These results indicate that a porcine model of FANCA holds promise for the development of strategies to prevent the development of bone marrow failure and malignancies in patients with FA.

MeSH terms

  • Animals
  • Disease Models, Animal*
  • Fanconi Anemia Complementation Group A Protein / genetics
  • Fanconi Anemia Complementation Group A Protein / metabolism
  • Fanconi Anemia Complementation Group D2 Protein / genetics
  • Fanconi Anemia Complementation Group D2 Protein / metabolism
  • Fanconi Anemia* / genetics
  • Fanconi Anemia* / metabolism
  • Fanconi Anemia* / pathology
  • Hematopoiesis
  • Hematopoietic Stem Cells / metabolism
  • Humans
  • Mitomycin / pharmacology
  • Swine

Substances

  • Fanconi Anemia Complementation Group A Protein
  • Fanconi Anemia Complementation Group D2 Protein
  • Mitomycin